Catalyst
Slingshot members are tracking this event:
Alnylam (ALNY) Announces Data Monitoring Committee Recommends Continuation of Phase 3 APOLLO Study Evaluating Patisiran in Hereditary ATTR Amyloidosis
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ALNY |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 10, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Data Monitoring Committee, Continuation, Phase 3, Apollo, Patisiran, Hereditary Attr Amyloidosis
